C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 84 filers reported holding C4 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 248,252 | $461,749 | 0.00% |
| GOLDMAN SACHS GROUP INC | 218,723 | $406,825 | 0.00% |
| MORGAN STANLEY | 313,077 | $582,324 | 0.00% |
| Invesco Ltd. | 56,391 | $104,887 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 28,014 | $51 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 15,223 | $28,315 | 0.00% |
| BlackRock Inc. | 2,095,338 | $3,897,329 | 0.00% |
| Qube Research & Technologies Ltd | 6,886 | $12,808 | 0.00% |
| ROYAL BANK OF CANADA | 5,804 | $11,000 | 0.00% |
| Bank of New York Mellon Corp | 20,871 | $38,820 | 0.00% |
| Citadel Advisors | 8,600 | $15,996 | 0.00% |
| Citadel Advisors | 15,700 | $29,202 | 0.00% |
| Citadel Advisors | 393,942 | $732,732 | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC | 15,471 | $29 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 161,863 | $301,065 | 0.00% |
| Cresset Asset Management, LLC | 25,000 | $46,500 | 0.00% |
| BARCLAYS PLC | 43,614 | $81 | 0.00% |
| Daiwa Securities Group Inc. | 142 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 9,135 | $16,991 | 0.00% |
| UBS Group AG | 321,609 | $598,193 | 0.00% |
External links
This page lists C4 THERAPEUTICS INC's shareholders in Q3 2023. To view C4 THERAPEUTICS INC's shareholder history, click here.